DGAPNews MorphoSys AG Key words Study17.01.2019 2201 The issuer is solely responsible for the content of this announcement.PlaneggMunich Germany January 17 2019 MorphoSys Announces that its Licensee Janssen has Expanded Clinical Development of Guselkumab...
↧